T2 Biosystems Inc.

T2 Biosystems Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.25
Market Cap
$74.49 M
Shares Outstanding
44.34 M
Public Float
35.13 M

Profile

Address
101 Hartwell Avenue
Lexington Massachusetts 02421
United States
Employees -
Website http://www.t2biosystems.com
Updated 07/08/2019
T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection including one colony forming unit per milliliter. The company was founded by Michael J.

Financials

View All

Seymour E. Liebman
Director
Adrian M. Jones
Independent Director